ClinVar Miner

Submissions for variant NM_004260.4(RECQL4):c.215C>T (p.Ala72Val)

gnomAD frequency: 0.00005  dbSNP: rs763453097
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000470370 SCV000545945 uncertain significance Baller-Gerold syndrome 2024-10-21 criteria provided, single submitter clinical testing This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 72 of the RECQL4 protein (p.Ala72Val). This variant is present in population databases (rs763453097, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with RECQL4-related conditions. ClinVar contains an entry for this variant (Variation ID: 406973). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Not Available". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
St. Jude Molecular Pathology, St. Jude Children's Research Hospital RCV001543123 SCV001761640 uncertain significance Rothmund-Thomson syndrome type 2 2021-06-24 criteria provided, single submitter clinical testing The RECQL4 c.215C>T (p.Ala72Val) missense change is present at a maximum subpopulation frequency of 0.039% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/variant/8-145742573-G-A). In silico tools predict a benign effect of this variant on protein function (BP4), but to our knowledge these predictions have not been confirmed by functional assays. To our knowledge, this variant has not been reported in individuals with RECQL4-associated disorders. In summary, this variant meets criteria to be classified as of uncertain significance based on the ACMG/AMP criteria: BP4.
Laboratory of Molecular Epidemiology of Birth Defects, West China Second University Hospital, Sichuan University RCV003153603 SCV003843336 benign Ovarian cancer 2022-01-01 criteria provided, single submitter clinical testing
GeneDx RCV004794389 SCV005415383 uncertain significance not provided 2024-05-24 criteria provided, single submitter clinical testing In silico analysis indicates that this missense variant does not alter protein structure/function; Observed in an individual with colorectal cancer (PMID: 31360874); This variant is associated with the following publications: (PMID: 29641532, 31360874)

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.